Federal Judge Rules In Favor Of Sanofi, Regeneron In Patent Suit Over Cholesterol Drugs

The decision was a loss for Amgen, which had claimed that Sanofi and Regeneron’s drug Praluent infringed on its patents for the drug Repatha.

from Above the Law https://ift.tt/2zvQBsn
via Solicitors In Lagos Nigeria



from WordPress https://ift.tt/2LgImph
via Law firms in Nigeria

Comments

Popular posts from this blog

WeWork Probably Won’t Be Taking Saudi Money When It Goes Public Because It’s Maybe Starting To Get How This Works

Morning Docket: 08.30.19